| Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production M Umezu-Goto, Y Kishi, A Taira, K Hama, N Dohmae, K Takio, T Yamori, ... J cell biol 158 (2), 227-233, 2002 | 1077 | 2002 |
| Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors R Hoshino, Y Chatani, T Yamori, T Tsuruo, H Oka, O Yoshida, Y Shimada, ... Oncogene 18 (3), 813-822, 1999 | 906 | 1999 |
| Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor S Yaguchi, Y Fukui, I Koshimizu, H Yoshimi, T Matsuno, H Gouda, ... Journal of the National Cancer Institute 98 (8), 545-556, 2006 | 479 | 2006 |
| Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 385 | 2001 |
| Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide L Yang, T Mashima, S Sato, M Mochizuki, H Sakamoto, T Yamori, ... Cancer research 63 (4), 831-837, 2003 | 377 | 2003 |
| Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel T Yamori, A Matsunaga, S Sato, K Yamazaki, A Komi, K Ishizu, I Mita, ... Cancer research 59 (16), 4042-4049, 1999 | 346 | 1999 |
| Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 K Hama, J Aoki, M Fukaya, Y Kishi, T Sakai, R Suzuki, H Ohta, T Yamori, ... Journal of Biological Chemistry 279 (17), 17634-17639, 2004 | 330 | 2004 |
| An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines S Dan, T Tsunoda, O Kitahara, R Yanagawa, H Zembutsu, T Katagiri, ... Cancer Research 62 (4), 1139-1147, 2002 | 318 | 2002 |
| A human IAP-family gene, apollon, expressed in human brain cancer cells Z Chen, M Naito, S Hori, T Mashima, T Yamori, T Tsuruo Biochemical and biophysical research communications 264 (3), 847-854, 1999 | 314 | 1999 |
| Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid Y Kishi, S Okudaira, M Tanaka, K Hama, D Shida, J Kitayama, T Yamori, ... Journal of Biological Chemistry 281 (25), 17492-17500, 2006 | 280 | 2006 |
| Development of cDNA microarray for expression profiling of estrogen responsive genes A Inoue, N Yoshida, Y Omoto, S Oguchi, T Yamori, R Kiyama, S Hayashi Journal of Molecular Endocrinology 29 (2), 175-192, 2002 | 275 | 2002 |
| Blockade of the stromal cell–derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor–independent manner B Guleng, K Tateishi, M Ohta, F Kanai, A Jazag, H Ijichi, Y Tanaka, ... Cancer research 65 (13), 5864-5871, 2005 | 272 | 2005 |
| Expression, function, and clinical implications of the estrogen receptor β in human lung cancers Y Omoto, Y Kobayashi, K Nishida, E Tsuchiya, H Eguchi, K Nakagawa, ... Biochemical and biophysical research communications 285 (2), 340-347, 2001 | 268 | 2001 |
| Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting M Murakami, H Cabral, Y Matsumoto, S Wu, MR Kano, T Yamori, ... Science translational medicine 3 (64), 64ra2-64ra2, 2011 | 265 | 2011 |
| Effect on tumor cells of blocking survival response to glucose deprivation HR Park, A Tomida, S Sato, Y Tsukumo, J Yun, T Yamori, Y Hayakawa, ... Journal of the National Cancer Institute 96 (17), 1300-1310, 2004 | 256 | 2004 |
| Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy D Kong, T Yamori Cancer science 99 (9), 1734-1740, 2008 | 252 | 2008 |
| Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma SD Hoff, Y Matsushita, DM Ota, KR Cleary, T Yamori, S Hakomori, ... Cancer research 49 (24 Part 1), 6883-6888, 1989 | 251 | 1989 |
| Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1) A Komuro, T Imamura, M Saitoh, Y Yoshida, T Yamori, K Miyazono, ... Oncogene 23 (41), 6914-6923, 2004 | 247 | 2004 |
| Insulin and insulin‐like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26 M Koenuma, T Yamori, T Tsuruo Japanese journal of cancer research 80 (1), 51-58, 1989 | 237 | 1989 |
| Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities Y Mizui, T Sakai, M Iwata, T Uenaka, K Okamoto, H Shimizu, T Yamori, ... The Journal of antibiotics 57 (3), 188-196, 2004 | 230 | 2004 |
